LSP launches US-$600m European life sciences fund
LSP 6 will, like its predecessor funds, invest in 15 to 18, predominantly European private companies developing new medicines or medical...
BioNTech SE’s COVID-19 vaccine attracts investment
Under the deal, Chinese Fosun Pharmaceutical (Group) Co., Ltd (Shanghai) will pay up to US$135m (€120m) upfront and in milestones, including an...
New resource models human metabolism
In Science Translational Medicine, the team under Jonathan Robinson from at Chalmers University of Technology in Gothenburg reported that their model...
Antabio SAS advances cystic fibrosis programme
Antabio said it will use the second tranche of a 2017 CARB-X grant to complete non-GLP studies on the company‘s Pseudomonas Elastase inhibitor (PEi)...
Sleeping sickness target deciphered
Using ultra-bright X-ray flashes, a team of researchers led by Lars Redecke from the University of Lübeck and DESY, Christian Betzel from the...
HepaRegeniX: €11m for liver disease treatment
In preclinical studies, HepaRegeniX’ MKK4 inhibitor had demonstrated efficacy in liver regeneration and experimental acute and chronic liver disease...
Agriculture ministers commit to global trade rules
The Agriculture Ministers’ Conference agreed on the following objectives: global rules for global markets, strengthening of the WTO, bilateral...